Five things to know:
1. The neuroscience business saw fourth quarter revenue of $2.3 billion, unchanged from the same time last year. For the entire 2022 fiscal year, revenue was $8.8 billion, a 7 percent increase from last year.
2. Cranial and spinal technologies in the fourth quarter saw a 2 percent decrease in sales year over year with $1.2 billion.
3. Fourth quarter revenue of $8.1 billion was a 1 percent decrease year over year.
4. Total revenue in fiscal year 2022 grew 5 percent compared to fiscal year 2021.
5. Medtronic’s quarterly dividend increased 8 percent year over year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.